Prevalence and typing of human papilloma virus (HPV) among female sex workers and outpatient women in southern Thailand
Verapol Chandeying A B C F , Suzanne M. Garland D E and Sepehr N. Tabrizi D EA Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Hat Yai 90110, Thailand.
B Department of Obstetrics and Gynecology, Hat Yai Center Hospital, Hat Yai 90110, Thailand.
C Hat Yai VD Unit, Hat Yai 90110, Thailand.
D Department of Microbiology and Infectious Diseases, The Royal Women’s Hospital, Carlton, Vic. 3053, Australia.
E Department of Obstetrics and Gynaecology, University of Melbourne, Carlton, Vic. 3053, Australia.
F Corresponding author. Email: verapol.c@psu.ac.th
Sexual Health 3(1) 11-14 https://doi.org/10.1071/SH05019
Submitted: 3 April 2005 Accepted: 4 November 2005 Published: 20 February 2006
Abstract
Background: Thai sex workers (SW) have high rates of sexually transmitted infections (STIs); however, detection and treatment is often complicated by accessibility to sensitive and accurate diagnostic tests. Self-sampling of women combined with molecular amplification techniques could help in accurate diagnosis, treatment and follow-up of such women. Detection of persistent high-risk human papilloma virus (HPV) in such populations could also be beneficial in identifying women who may need more frequent follow-up for cervical cytology screening. The current study aimed to examine the prevalence of HPV in this population and compare this with the lower-risk outpatient women (OPW) in Thailand. Methods: Four hundred and thirty OPW and 524 Thai SW were sampled by a self-administered tampon collection. Cells were extracted from tampons and, subsequently, women underwent routine vaginal examination for detection of other STIs. Detection of HPV was performed by polymerase chain reaction (PCR) using the L1 consensus primers, followed by L1 consensus probe using an in-house PCR-enzyme-linked immunosorbent assay (ELISA). All positive samples were typed using PCR-ELISA and type-specific oligonucleotide probes. Results: Overall, HPV was detected in 20/430 (4.6%) and 120/524 (22.9%) in OPW and SW respectively. Over 98% of samples produced a β-globin signal, indicating adequately collected samples. Human papilloma virus typing probes detected HPV16 or 18 in 14% and 26% of the positive samples from OPW and SW respectively. HPV31, 33, 35 or 39 were detected in 19% and 12% and HPV45, 51 or 52 in 9.5% and 4% of positive OPW and SW patients respectively. Low risk HPV6 or 11 were detected in 1% and 4.9% of OPW and SW respectively. Conclusion: There was a significantly higher HPV prevalence in Thai SW than OPW, with the majority (21%) of positive samples containing the oncogenic HPV16 or 18 DNA. The results indicate that PCR could serve as a rapid and easy method for identification of women who require more frequent screening for cervical cancer.
Additional keywords: polymerase chain reaction, women, tampon.
Acknowledgements
We are grateful to the staffs of Hat Yai VD unit, Department of Obstetrics and Gynaecology, Hat Yai Centre Hospital, and Department of Virology and Immunology, Prince of Songkla University, Hat Yai, Songkla, for their assistance during the trial.
[1] Kiviat NB, Koutsky LA, Critchlow CW, Lorincz AT, Cullen AP, Brockway J, et al. Prevalence and cytologic manifestations of human papillomavirus (HPV) types 6, 11, 16, 18, 31, 33, 35, 42, 43, 44, 51, and 56 among 500 consecutive women. Int J Gynecol Path. 1992; 11(3): 197–203.
[2] Munoz N, Bosch FX, de Sanjose S, Shah KV. The role of HPV in the etiology of cervical cancer. Mutat Res 1994; 305(2): 293–310.
| PubMed |
[3]
[4] Clifford M, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwides: a meta-analysis. Br J Cancer 2003; 88(1): 63–73.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[5] Chandeying V, Lamlertkittikul S, Skov S. A comparison of first-void urine, self-administered low vaginal swab, self-inserted tampon, and endocervical swab using PCR tests for the detection of infection with Chlamydia trachomatis Sex Health 2004; 1(1): 51–4.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[6] Fairley CK, Chen S, Tabrizi SN, Quinn MA, McNeil JJ, Garland SM. Tampons: a novel patient-administered method for the assessment of genital human papillomavirus infection. J Infect Dis 1992; 165(6): 1103–6.
| PubMed |
[7] Bauer HM, Ting Y, Greer CE, Chambers JC, Tashiro CJ, Chimera J, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991; 265 472–7.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[8] Bowden FJ, Tabrizi SN, Paterson BA, Garland SM, Fairley CK. Determination of genital human papillomavirus genotypes in women in Northern Australia using a novel, self-administered tampon technique. Int J Gynaecol Cancer 1998; 8 471–5.
| Crossref | GoogleScholarGoogle Scholar |
[9] Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia. Lancet 1992; 339(8799): 959–60.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[10] Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer 1994; 69(1): 167–71.
| PubMed |
[11] Bory JP, Cucherousset J, Lorenzato M, Gabriel R, Quereux C, Birembaut P, et al. Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical lesions: a longitudinal study of 3,091 women. Int J Cancer 2002; 102(5): 519–25.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[12] Cuzick J, Szarewski A, Terry G, Ho L, Hanby A, Maddox P, et al. Human papillomavirus testing in primary cervical screening. Lancet 1995; 345(8964): 1533–6.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[13] Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 2003; 362(9399): 1871–6.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[14] Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 1995; 87(11): 796–802.
| PubMed |
[15] Chichareon S, Herrero R, Munoz N, Bosch FX, Jacobs MV, Deacon J, et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 1998; 90(1): 50–7.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[16] Thomas DB, Ray RM, Koetsawang A, Kiviat N, Kuypers J, Qin Q, et al. Human papillomaviruses and cervical cancer in Bangkok. I. Risk factors for invasive cervical carcinomas with human papillomavirus types 16 and 18 DNA. Am J Epidemiol 2001; 153(8): 723–31.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[17] Siritantikorn S, Laiwejpithaya S, Siripanyaphinyo U, Auewarakul P, Yenchitsomanus P, Thakernpol K, et al. Detection and typing of human papilloma virus DNAs in normal cervix, intraepithelial neoplasia and cervical cancer in Bangkok. Southeast Asian J Trop Med Public Health 1997; 28(4): 707–10.
| PubMed |
[18] Thomas DB, Qin Q, Kuypers J, Kiviat N, Ashley RL, Koetsawang A, et al. Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas. Am J Epidemiol 2001; 153(8): 732–9.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[19] Lertworapreecha M, Bhattarakosol P, Niruthisard S. Detection and typing of human papillomavirus in cervical intraepithelial neoplasia grade III in Thai women. Southeast Asian J Trop Med Public Health 1998; 29(3): 507–11.
| PubMed |
[20] Bhattarakosol P, Lertworapreecha M, Kitkumthorn N, Triratanachai S, Niruthisard S. Survey of human papillomavirus infection in cervical intraepithelial neoplasia in Thai women. J Med Assoc Thai 2002; 85 S360–5.
| PubMed |
[21] Sukvirach S, Smith JS, Tunsakul S, Munoz N, Kesararat V, Opasatian O, et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. Infect Dis. 2003; 187(8): 1246–56.
| Crossref | GoogleScholarGoogle Scholar |
[22] Thongkrajai P, Pengsaa P, Lulitanond V. An epidemiological survey of female reproductive health status: gynecological complaints and sexually-transmitted diseases. Southeast Asian J Trop Med Public Health 1999; 30(2): 287–95.
| PubMed |
[23] Mak R, Renterghem L, Cuvelier C. Cervical smears and human papillomavirus typing in sex workers. Sex Transm Infect 2004; 80(2): 118–20.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[24] Lack N, West B, Jeffries D, Ekpo G, Morison L, Soutter WP, et al. Comparison of non-invasive sampling methods for detection of HPV in rural African women. Sex Transm Infect 2005; 81(3): 239–41.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
